Do you want to read an article? Please log in or register.
Rhegmatogenous Retinal Detachment Following Intravitreal Injection of Anti-Vascular Endothelial Growth Factor
Retinal Diseases
Related content
COMMENTED
Retinal Diseases
Multicentre study of 4626 patients assesses the effectiveness, safety and burden of two categories of treatments for central retinal vein occlusion: intravitreal anti-vascular endothelial growth factor injections and intravitreal Ozurdex injections
★ 2
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
Br J Ophthalmol
Gale R, Gill C, Pikoula M, Lee AY, Hanson RLW, Denaxas S, Egan C, Tufail A, Taylor P, UK EMR Database Users Group.
doi: 10.1136/bjophthalmol-2020-317306
COMMENTED
Macular DiseasesRetinal Diseases
IMPACT OF LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON PREEXISTING MICROSTRUCTURAL ALTERATIONS IN DIABETIC MACULAR EDEMA
Retina.
Wirth MA, Wons J, Freiberg FJ, Becker MD, Michels S
doi: 10.1097/IAE.
COMMENTED
Macular DiseasesRetinal Diseases
INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Retina.
Vazquez-Alfageme C, Nicholson L, Hamilton RD, Patel PJ
doi: 10.1097/IAE.
Further Publications
Retinal Detachment After Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti-Vascular Endothelial Growth Factor
Ophthalmology
Barry GP, Yu Y, Ying GS, Tomlinson LA, Lajoie J, Fisher M, Binenbaum G
doi: 10.1016/j.ophtha.2020.12.028
Macular DiseasesRetinal Diseases
Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser
Br J Ophthalmol.
Gale R, Pikoula M, Lee AY, Denaxas S, Egan C, Tufail A, Taylor P, UK EMR Users Group.
doi: 10.1136/bjophthalmol-2020-315836.
Cornea and Corneal DiseasesConjunctivitisBlindness and Vision ImpairmentFlammer SyndromeGlaucoma and Ocular PressureLensesMacular DiseasesOcular OncologyRetinal DiseasesSurgery and InterventionUveitisCataractsDry Eye Disease
Changes in Treatment-Naive Pigment Epithelial Detachments Associated With the Initial Anti-Vascular Endothelial Growth Factor Injection: A Post Hoc Analysis From the HARBOR Trial
JAMA Ophthalmol
Javaheri M, Hill L, Ghanekar A, Stoilov I
doi: 10.1001/jamaophthalmol.2020.5130
COMMENTED
Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti-Vascular Growth Factor Agents in a Nationwide Study in France
JAMA Ophthalmol.
Baudin F, Benzenine E, Mariet AS, Bron AM, Daien V, Korobelnik JF, Quantin C, Creuzot-Garcher C
doi: 10.1001/
COMMENTED
Macular Diseases
Association of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration
JAMA Ophthalmol.
Dalvin LA, Starr MR, AbouChehade JE, Damento GM, Garcia M, Shah SM, Hodge DO, Meissner I, Bakri SJ,
Iezzi R
doi: 10.1001/jamaophthalmol.
COMMENTED
Macular Diseases
Outcomes of Eyes Lost to Follow-up with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Anti-Vascular Endothelial Growth Factor
Ophthalmol Retina.
Soares RR, Mellen P, Garrigan H, Obeid A, Wibbelsman TD, Borkar D, Ho AC, Hsu J
doi: 10.1016/j.oret.2019.07.010.